Glenmark - Approaching Strong supportGlenmark ::
Approaching strong support currently
Looks weak below 1600
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−31.00 INR
−15.02 B INR
118.13 B INR
137.41 M
About GLENMARK PHARMACEUTICALS
Sector
CEO
Glenn Mario Saldanha
Headquarters
Mumbai
Website
Founded
1977
ISIN
INE935A01035
FIGI
BBG000BJ3V03
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the following geographical segments: India, North America, Europe, Latin America, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.
#GLENMARK Setting Up for a Pre-Breakout!💊 Stock Alert: #GLENMARK Setting Up for a Pre-Breakout! 💊
📈 Ready for Another Run: After a previous breakout attempt was halted by market volatility, #GLENMARK is now showing renewed strength, rebounding off support as the pharma sector gains momentum. This time, the stock is forming a Darvas Box—a
GLENMARK - 4th wave down startedGLENMARK CMP 1640
Whether you call it breakout retest or Wave.. A touchown to 1260 is very much due.. levels are marked for 4th wave targets..
Glenmark Glenmark
Maximum pharma sectors bullish now, This stock good resistance zoon, so 1810 Above not sustain take selling... Entry1780 Bellow close only
SL 1Hr candle close only, Target Trigger Price
All detail for chat. good entry at mark price only. and must stoploss minimum risk and good profit. r
Glenmark pharma long callPrice Action and Trend Analysis:-
The stock has shown a consistent upward trend over the past few months, indicating strong bullish momentum. Recent price movements have formed higher highs and higher lows, which is characteristic of an uptrend.
The price level at 1700 serves as a critical support
GLENMARK // LEVEL // 3H"Welcome to SkyTradingZone "
Hello Everyone 👋
Let's take a closer look at the 3-hour candlestick chart for Glenmark Pharmaceuticals Limited (GLENMARK), a leading Indian pharmaceutical company.
Here are some key insights based on the 3-hour chart:
Current Trend: GLENMARK has been trading in an up
Glenmark ShortPotential Reversal : 1645-1647
SL 1700
Target 1590,1555,1525
Trade should be initiated based on price action.
Ride with FlowGlenmark is one more example of confluence with level
Breaking previous week high as well as well as VAH(value area High
Only for education purpose
GLENMARK PHARMA READY FOR A GARANTUAN BREAKOUTThe stock has been forming a cup and handle pattern on the weekly time frame where the 965 level is acting as a crucial resistance however it can be shattered if the market sentiments favour and after that a prelonged rally , however a major concern for the company is its ailing balance sheet which
ATH_GLENMARK_Hi Traders,
Happy to share this post since Tracking it from last couple of months and today it closed above Previous levels with Strong Bullish pinbar at 20 EMA support in uptrend.
Pros:-Bullish Pinbar in uptrend which is taking 20 EMA as support.
:- Energy is being stored from last couple o
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GLENMARK is 1,492.80 INR — it has increased by 0.86% in the past 24 hours. Watch GLENMARK PHARMACEUTICALS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange GLENMARK PHARMACEUTICALS LTD. stocks are traded under the ticker GLENMARK.
GLENMARK stock has fallen by −4.41% compared to the previous week, the month change is a −11.04% fall, over the last year GLENMARK PHARMACEUTICALS LTD. has showed a 92.61% increase.
We've gathered analysts' opinions on GLENMARK PHARMACEUTICALS LTD. future price: according to them, GLENMARK price has a max estimate of 2,036.00 INR and a min estimate of 1,345.00 INR. Watch GLENMARK chart and read a more detailed GLENMARK PHARMACEUTICALS LTD. stock forecast: see what analysts think of GLENMARK PHARMACEUTICALS LTD. and suggest that you do with its stocks.
GLENMARK reached its all-time high on Oct 15, 2024 with the price of 1,830.05 INR, and its all-time low was 19.65 INR and was reached on Nov 5, 2003. View more price dynamics on GLENMARK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GLENMARK stock is 1.81% volatile and has beta coefficient of 0.50. Track GLENMARK PHARMACEUTICALS LTD. stock price on the chart and check out the list of the most volatile stocks — is GLENMARK PHARMACEUTICALS LTD. there?
Today GLENMARK PHARMACEUTICALS LTD. has the market capitalization of 417.65 B, it has decreased by −1.23% over the last week.
Yes, you can track GLENMARK PHARMACEUTICALS LTD. financials in yearly and quarterly reports right on TradingView.
GLENMARK PHARMACEUTICALS LTD. is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
GLENMARK PHARMACEUTICALS LTD. revenue for the last quarter amounts to 34.34 B INR, despite the estimated figure of 34.89 B INR. In the next quarter, revenue is expected to reach 34.50 B INR.
GLENMARK net income for the last quarter is 3.54 B INR, while the quarter before that showed 3.40 B INR of net income which accounts for 4.10% change. Track more GLENMARK PHARMACEUTICALS LTD. financial stats to get the full picture.
Yes, GLENMARK dividends are paid annually. The last dividend per share was 2.50 INR. As of today, Dividend Yield (TTM)% is 0.17%. Tracking GLENMARK PHARMACEUTICALS LTD. dividends might help you take more informed decisions.
As of Nov 25, 2024, the company has 16.29 K employees. See our rating of the largest employees — is GLENMARK PHARMACEUTICALS LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLENMARK PHARMACEUTICALS LTD. EBITDA is 14.86 B INR, and current EBITDA margin is 10.43%. See more stats in GLENMARK PHARMACEUTICALS LTD. financial statements.
Like other stocks, GLENMARK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLENMARK PHARMACEUTICALS LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLENMARK PHARMACEUTICALS LTD. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLENMARK PHARMACEUTICALS LTD. stock shows the buy signal. See more of GLENMARK PHARMACEUTICALS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.